Albendazole Dose Finding and Pharmacokinetics in Children and Adults
Efficacy and Safety of Ascending Dosages of Albendazole Against T. Trichiura and Hookworm in Preschool- and School-aged Children and Adults: a Randomized Controlled Trial
Sponsor: Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
This PHASE2 trial investigates Hookworm Infections and Trichuriasis and is currently completed. Centre Suisse de Recherches Scientifiques en Cote d'Ivoire leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Feb 2021 — Jul 2023 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Oct 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2019 — Oct 2019 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Suisse de Recherches Scientifiques en Cote d'Ivoire
- Jennifer Keiser
For direct contact, visit the study record on ClinicalTrials.gov .